WELLNESS BY DESIGN Trademark
Trademark Overview
On Wednesday, March 30, 2022, a trademark application was filed for WELLNESS BY DESIGN with the United States Patent and Trademark Office. The USPTO has given the WELLNESS BY DESIGN trademark a serial number of 97339107. The federal status of this trademark filing is OPPOSITION PENDING as of Tuesday, March 28, 2023. This trademark is owned by Fig Life Sciences LLC. The WELLNESS BY DESIGN trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting sensory organs; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparation for skin care; Pharmaceutical preparations for skin care; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for the central nervous system; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the prevention of thrombosis; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical prepar...
General Information
| Serial Number | 97339107 |
| Word Mark | WELLNESS BY DESIGN |
| Filing Date | Wednesday, March 30, 2022 |
| Status | 774 - OPPOSITION PENDING |
| Status Date | Tuesday, March 28, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 28, 2023 |
Trademark Statements
| Goods and Services | Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting sensory organs; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparation for skin care; Pharmaceutical preparations for skin care; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for the central nervous system; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the prevention of thrombosis; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparations for the treatment of inflammation; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypoglycemia; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for treating sunburn; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations, namely, elixirs for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the treatment of infectious diseases; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for the treatment of viral diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical skin lotions; Anti-diabetic pharmaceuticals; Anti-epileptic pharmaceutical preparations; Balms for pharmaceutical purposes; Dermatological pharmaceutical products; Digestives for pharmaceutical purposes; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Plant extracts for pharmaceutical purposes; Plant extracts for medical, veterinary and pharmaceutical purposes; Potassium preparations for pharmaceutical purposes; Yeast for pharmaceutical consumption |
| Disclaimer with Predetermined Text | "WELLNESS" |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, April 5, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Fig Life Sciences LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | reno, NV 89502 |
| Party Name | Fig Life Sciences LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | reno, NV 89502 |
Trademark Events
| Event Date | Event Description |
| Tuesday, March 28, 2023 | OPPOSITION INSTITUTED NO. 999999 |
| Tuesday, March 28, 2023 | OPPOSITION PAPERS RECEIVED AT TTAB |
| Tuesday, February 28, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 28, 2023 | PUBLISHED FOR OPPOSITION |
| Wednesday, February 8, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, January 23, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Saturday, January 21, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Saturday, January 21, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Saturday, January 21, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Saturday, January 21, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, January 13, 2023 | ASSIGNED TO EXAMINER |
| Tuesday, April 5, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, April 2, 2022 | NEW APPLICATION ENTERED |
